Comparative Study of Vaccine for COVID-19 Available in India

Authors

  • Chandani Kamble Student, Department of Pharmaceutical Quality Assurance, Ashokrao Mane College of Pharmacy Peth Vadgaon, Kolhapur, Maharashtra, India
  • Sharad Kamble Assistant Professor, Department of Pharmaceutics, Nootan College of Pharmacy, Kavathemahankal, Maharashtra, India
  • Shubham Hanfode Student, Department of Pharmacy, Nootan College of Pharmacy, Kavathemahankal, Maharashtra, India
  • Appasab Tanvashi Student, Department of Pharmacy, Nootan College of Pharmacy, Kavathemahankal, Maharashtra, India
  • Prathmesh Kore Student, Department of Pharmacy, Nootan College of Pharmacy, Kavathemahankal, Maharashtra, India

Keywords:

Coronavirus, COVID-19, vaccines, SARS-CoV-2, organizations

Abstract

The enduring SARS-CoV-2 deadly disease has led to the focused application of resources and scientific knowledge toward the target of developing investigational vaccines to avoid COVID-19. The greatly collaborative global hard work by private industry, governments, and non-governmental organizations has resulted in several SARS-CoV-2 vaccines. In this review, we provide an overview of the description, vaccine characteristic, developers, and action of vaccine, dose & efficacy of vaccines on Covid-19.

References

Jon C, Russia’s claim of a successful COVID-19 vaccine doesn’t pass the ‘smell test,’ critics say, Science (2020),Available online at: https://www.science.org/content/article/russia-s-claim-successful-covid-19-vaccine-doesn-t-pass-smell-test-critics-say

S. V, The Sputnik V Vaccine’s Efficacy is Confirmed at 91.4% based on Data Analysis of the Final Control Point of Clinical Trials, 2020. Available online at: https://sputnikvaccine.com/newsroom/pressreleases/the-sputnik-v-vaccine-s-efficacy-is-confirmed-at-91-4-based-on-data-analysis-of-the-final-control-po/

Balakrishnan V. S. The arrival of Sputnik V, Lancet 2020 Oct;20(10):1128.

Covishield Vaccine Registration, Efficacy rate, Side Effects, Dose Gap. My Personal News for Recruitment and Counselling–MPNRC.Org, 2021 August 11. https://www.mpnrc.org/covishield-vaccine-registration/

Summary of product characteristics. Sputnik V. Gam-COVID-Vac Combined vector vaccine for the prevention of coronavirus infection caused by the SARS-CoV-2 virus. pp-1-9. Available online at: https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/Up-loadSmPC/SMPCspu-tinikdr.Reddys.pdf

Jones I, Sputnik V COVID-19 vaccine candidate appears safe and effective; The Lancet 2021 Feb 20;397(10275):642-643.

Raghavan P. Sputnik V now in India: what is the price of Russian vaccine? Indian Express. 2021 May 14. Available online at: https://timesofindia.indiatimes.com/india/sputnik-v-covid-19-vaccine-in-india-all-you-need-to-know/articleshow/83167470.cms

Sputnik Vaccine Registration, Efficacy, Price, Side Effects, Dose Gap. My Personal News for Recruitment and Counselling–MPNRC.Org, 2021 August 11. Available online at: https://www.mpnrc.org/sputnik-vaccine-registration-efficacy-price-side-effects-dose-gap/

Haidar S. More than three million doses of the Russian vaccine will be available by this month. THE HINDU. 2021 May 22. Available online at: https://www.thehindu.com/news/national/coronavirus-more-than-18-million-doses-of-sputnik-v-to-be-made-available-in-india-from-august/article34623321.ece

Covaxin Wikipedia https://en.m.wikipedia.org/wiki/Covaxin

Covaxin-fact-sheet, COVID-19 Vaccine (COVAXIN), Bharat Biotech international Limited. Available online at: https://www.bharatbiotech.com/images/covaxin/covaxin-factsheet.pdf

Parkins K. Covaxin: India’s homegrown COVID-19 vaccine brings hope and controversy. Clinical Trials Arena. 2021 April 27. https://www.clinicaltrialsarena.com/analysis/covaxin-indias-homegrown-covid-19-vaccine-brings-hope-and-controversy/

Corum J. and Zimmer C. How Bharat Biotech’s vaccine works. The New York Times. 2021 May 7. https://www.nytimes.com/interactive/2021/health/bharat-biotech-covid-19-vaccine.html

Bharat biotech covaxin–India’s first Indigenous COVID-19 vaccine. https://www.bharat-biotech.com/covaxin.html

Jeong M. Covaxin COVID-19 vaccine: what to know about side effects. Medical News Today. 2021 June 4. https://www.medicalnewstoday.com/articles/covaxin-covid-19-vaccine-what-to-know-about-side-effects

BS Web Team & Agencies, Covaxin showed 81% interim efficacy: Bharat Biotech on Phase 3 results: Covaxin demonstrates significant immunogenicity against the rapidly emerging variants, says Bharat Biotech CMD. Business Standard. 2021 March 3. https://www.business-standard.com/article/current-affairs/covaxin-showed-81-interim-efficacy-bharat-biotech-on-phase-3-results-121030300966_1.html

Sanghi N. Are Bharat Biotech’s Price for Covaxin justified? Science The Wire. 2021 April 27. https://science.thewire.in/health/are-bharat-biotechs-prices-for-covaxin-justified/

BMJ 2021; 373: n997. What do we know about India’s Covaxin vaccine? https://www.bmj.com/content/373/bmj.n997

Ani. Bharat Biotech to ramp up production of Covaxin to 10-12 crore doses by July-end: Dr. NK Arora. The Times of India, 2021 May 31. https://timesofindia.indiatimes.com/india/bharat-biotech-to-ramp-up-production-of-covaxin-to-10-12-crore-doses-by-july-end-dr-nk-arora/articleshow/83114655.cms

Srivatsan K. C. Covishield: A timeline of the COVID-19 vaccine manufactured by Serum Institute of India. Hindustan Times. 2021 January 16. https://www.hindustantimes.com/india-news/covishield-a-timeline-of-the-covid-19-vaccine-manufactured-by-sii-101610818090162.html

Covaxin Vs Covishield Vs Sputnik Vs Pfizer which one should you get? https://www.policybazaar.com/health-insurance/coronavirus-health insurance/articles/compa-rison-covaxin-covishield-sputnikv-pfizer-all-about-covid-19-vaccines-approved-in-india/

Mellet, J., Pepper, M.S. A COVID-19 Vaccine: Big Strides Come with Big Challenges. Vaccines 2021 Jan 11;9(1):39.

Downloads

Published

2022-01-13

Issue

Vol. 11 No. 3 (2021)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.